"Rituximab hypersensitivity and desensitization: A personalized approach to treat cancer and connective tissue diseases".

"Rituximab hypersensitivity and desensitization: A personalized approach to treat cancer and connective tissue diseases". Ann Allergy Asthma Immunol. 2019 Mar 15;: Authors: Yang BC, Castells MC PMID: 30885801 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30885801?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - March 14, 2019 Category: Allergy & Immunology Authors: Yang BC, Castells MC Tags: Ann Allergy Asthma Immunol Source Type: research